Emcure Pharma (EMCURE)
FAST GROWERFairStock Score: 70/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,610.05 |
| Market Cap | ₹27,592.28 Cr |
| P/E Ratio | 30.51 |
| ROCE | 20.72% |
| ROE | 19.57% |
| Dividend Yield | 0.21% |
| Profit Growth | 43.19% |
| Debt/Equity | 0.35 |
| Sales Growth | 17.2% |
| Free Cash Flow | ₹75,600 Cr |
| Promoter Holding | 77.87% |
| 52-Week Range | ₹1,228.9 — ₹1,830.35 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹234.54 |
Emcure Pharma trades with a P/E ratio of 30.51, ROCE of 20.72%, ROE of 19.57%, profit growth of 43.19%, debt-to-equity of 0.35. The FairStock Score of 70/100 reflects strong fundamentals across multiple dimensions.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer